Cambridge Investment Research Advisors, Inc. Elevance Health, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Elevance Health, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 31,251 shares of ELV stock, worth $11.9 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
31,251
Previous 32,467
3.75%
Holding current value
$11.9 Million
Previous $17.6 Million
7.62%
% of portfolio
0.06%
Previous 0.07%
Shares
31 transactions
Others Institutions Holding ELV
# of Institutions
1,854Shares Held
196MCall Options Held
1.03MPut Options Held
1.24M-
Vanguard Group Inc Valley Forge, PA21.3MShares$8.16 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY20.7MShares$7.91 Billion0.26% of portfolio
-
State Street Corp Boston, MA10.7MShares$4.08 Billion0.23% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.2MShares$3.88 Billion0.61% of portfolio
-
Geode Capital Management, LLC Boston, MA4.85MShares$1.85 Billion0.21% of portfolio
About Elevance Health, Inc.
- Ticker ELV
- Exchange NYSE
- Sector Healthcare
- Industry Healthcare Plans
- Shares Outstandng 240,000,992
- Market Cap $91.7B
- Description
- Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....